Reading the tape
NASDAQ: ZCMD
Zhongchao Inc.
Healthcare · Medical - Healthcare Information Services
Market Cap
$6.73M
52w High
$12.18
52w Low
$1.44
P/E
-1.15
Volume
3.02K
Outstanding Shares
3.22M
Price vs Fundamentals
Why The Stock Is Moving
Likely fundamental deteriorationModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -77.67%Revenue (TTM): -28.3%FCF (TTM): 115.33%P/S: 25th pct
What changed
The stock fell 77.67% over the last year. Revenue declined 28.3% over the trailing twelve months. Operating margin moved from -2.15% to -54.43%. Free cash flow grew 115.33% over the trailing twelve months.
What the market seems to be pricing
The market is reacting to weaker business momentum more than just compressing the valuation multiple. Even if the shares already screen cheap on P/S, investors are still discounting lower future earnings power.
What would invalidate this read
Operating margin stands at -54.43%. Revenue declined 28.3% — this read reverses if that trend stabilizes. If margins and cash flow stabilize while the stock stays depressed, the gap shifts from fundamental damage toward pure multiple compression.
Company profile
Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China.
CEOWeiguang Yang
SectorHealthcare
IndustryMedical - Healthcare Information Services
Employees111
IPO dateFeb 25, 2020
Valuation
Forward P/E—
EV/EBITDA-0.72
Enterprise value$4.23M
Stock splits
Mar 2, 2026↓ Reverse
Every 8 shares became 1
Feb 29, 2024↓ Reverse
Every 10 shares became 1
Profitability & growth
Revenue growth-36.25%
Gross margin43.84%▼24.39%vs FY2024
Operating margin-54.43%▼2430.26%vs FY2024
ROE-33.87%▼997.23%vs FY2024
Analyst consensus
Rating—
Target price—
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 24, 2026
Q3 FY26 · EPS est — · Revenue est —
View